These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7719619)

  • 1. Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis.
    Krolick KA; Zoda TE; Thompson PA
    Adv Neuroimmunol; 1994; 4(4):475-93. PubMed ID: 7719619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
    Agius MA; Richman DP
    J Immunol; 1986 Oct; 137(7):2195-8. PubMed ID: 3489757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell vaccination in experimental myasthenia gravis: a double-edged sword.
    Kahn CR; McIntosh KR; Drachman DB
    J Autoimmun; 1990 Dec; 3(6):659-69. PubMed ID: 2150910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
    Zoda T; Yeh TM; Krolick KA
    J Immunol; 1991 Jan; 146(2):663-70. PubMed ID: 1987281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: subsetting of serum antibodies by preparative isoelectric focusing.
    Thompson PA; Krolick KA
    Clin Immunol Immunopathol; 1992 Feb; 62(2):199-209. PubMed ID: 1730158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
    Agius MA; Geannopoulos CJ; Fairclough RH; Richman DP
    J Immunol; 1988 Jan; 140(1):62-8. PubMed ID: 3257231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
    Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an idiotype associated with antibodies responsible for neuromuscular dysfunction in rats with experimental autoimmune myasthenia gravis.
    Thompson PA; Edlund SA; Krolick KA
    Clin Immunol Immunopathol; 1995 Apr; 75(1):57-67. PubMed ID: 7882593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma.
    Li HL; Shi FD; Bai XF; Huang YM; van der Meide PH; Xiao BG; Link H
    Clin Immunol Immunopathol; 1998 Apr; 87(1):15-22. PubMed ID: 9576006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody heterogeneity and specificity in myasthenia gravis.
    Vincent A; Whiting PJ; Schluep M; Heidenreich F; Lang B; Roberts A; Willcox N; Newsom-Davis J
    Ann N Y Acad Sci; 1987; 505():106-20. PubMed ID: 2446546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
    Ohtsuru I; Matsuo H; Fukudome T; Suenaga A; Tsujihata M; Nagataki S
    Clin Exp Immunol; 1995 Dec; 102(3):462-7. PubMed ID: 8536358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of an antiidiotypic antibody with acetylcholine-receptor-like binding properties from myasthenia gravis patients.
    Eng H; Lefvert AK
    Ann Inst Pasteur Immunol; 1988; 139(5):569-80. PubMed ID: 3264701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of immunological fine-specificity on the induction of experimental myasthenia gravis.
    Krolick KA; Thompson PA; Zoda TE; Yeh TM
    Ann N Y Acad Sci; 1993 Jun; 681():179-97. PubMed ID: 7689305
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo effects of neonatal administration of antiidiotype antibodies on experimental autoimmune myasthenia gravis.
    Verschuuren JJ; Graus YM; Van Breda Vriesman PJ; Tzartos S; De Baets MH
    Autoimmunity; 1991; 10(3):173-9. PubMed ID: 1756222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.
    Krolick KA; Yeh TM; Edlund SA
    Cell Immunol; 1996 Aug; 172(1):10-20. PubMed ID: 8806801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and structural characterization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus YM; De Baets MH
    Adv Neuroimmunol; 1994; 4(4):457-74. PubMed ID: 7719618
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of antibody responses to the acetylcholine receptor by natural antibodies.
    Sundblad A; Hauser S; Holmberg D; Cazenave PA; Coutinho A
    Eur J Immunol; 1989 Aug; 19(8):1425-30. PubMed ID: 2776827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.